We have demonstrated recently that Birbeck granule-positive Langerhans cells (LC) can be derived from CD34+ peripheral blood progenitor cells in the presence of a seven-cytokine cocktail (CC7-7). Here, we show that the sequential use of earty-acting hematopoietic growth factors, stem cell factor, interleukin (ILI-3, and 11-6, followed on day 8 by differentiation in the two-factor combination 11-4 plus granulocytemacrophage colony-stimulating factor (GM-GSF) (CC4GM) is more efficient and allows the cells t o be arrested in the LC stage for more than 1 week while continuous maturation occurs in CC7-7. Maturation of LC to interdigitating dendritic cells (DC) could specifically be induced within 60 hours by addtion of tumor necrosis factor-a (20 ng/mL) or lipopolysaccharide (100 ng/mL). Using LC that had been enriched to greater than 90% CDla' cells by an immunoaffinity column, we were able to define clear-cut differences between LC and DC that corroborate data of the respective cells derived from epithelial borders (LC) or from lymph nodes (LN) and spleen HE EFFECTIVE generation of antigen (AG)-specific T T-cell responses is based on an early AG uptake at the epithelial borders of the organism and subsequent presentation of these AGs at centers of T-cell traffic and activation, ie. lymph nodes (LN) and spleen.' AG uptake, transport, and presentation are supposed to be mediated by specialized subsets of dendritic cells? Langerhans cells (LC) in the skin and their counterparts in other epithelial tissues take up AG by micropinocytosis and macropinocytosis, and perhaps by phag~cytosis.~" Conco~tantly, they exhibit distinct functional changes, starting with their migration to the draining LN, where they finally home to the T-cell areas as interdigitating dendritic cells (DC) in order to present those AGs taken up in the periphery to induce naive or primed T cells?
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HE EFFECTIVE generation of antigen (AG)-specific
T T-cell responses is based on an early AG uptake at the epithelial borders of the organism and subsequent presentation of these AGs at centers of T-cell traffic and activation, ie. lymph nodes (LN) and spleen.' AG uptake, transport, and presentation are supposed to be mediated by specialized subsets of dendritic cells? Langerhans cells (LC) in the skin and their counterparts in other epithelial tissues take up AG by micropinocytosis and macropinocytosis, and perhaps by phag~cytosis.~" Conco~tantly, they exhibit distinct functional changes, starting with their migration to the draining LN, where they finally home to the T-cell areas as interdigitating dendritic cells (DC) in order to present those AGs taken up in the periphery to induce naive or primed T cells?
These data are mainly based on observations in mice in which the respective AG-presenting cells (APC) were isolated from skin, LN, or spleen. While similar data, skinderived LC/DC excepted, are difficult to obtain in humans, it was a major step forward when the in vitro generation of human DC from monocytes and hematopoietic progenitor cells was
We have recently shown that LC that express Birbeck granules can be generated from peripheral blood progenitor cells (PBPC) in vitro? To facilitate the analysis of the distinct subtypes of immature LCs and mature DCs, conditions for the controlled generation of these subsets from PBPCs have been evaluated. The cells were characterized with respect to morphology and phenotype, and their capacity to take up and present AG to autologous T cells.
MATERIALS AND METHODS
Cells were cultured in RPMI 1640 supplemented with 200 mmol/L L-glutamine, 50 p m o m P-mercaptoethanol, 100 mmoVL sodium pyruvate, 50 pg/mL streptomycin, 50 UI mL penicillin, minimal essential medium (MEM) vitamins, and 10% fetal calf serum (FCS) (56°C for 0.5 hours; Boehringer Mannheim, Mannheim, Germany). The following recombinant human cytokines were used interleukin (IL)-lp, IL-3, IL-4, stem cell factor (SCF), and tumor necrosis factor-a (TNF-a), all from Genzyme, Cambridge,
Media and reagents.
(DC). Thus, molecules and functions involved in antigen (A01 uptake and processing were highly expressed in LC, while those involved in AG presentation were at maximum in DC.
LC were CDla" DR++, CD23+, CD36' , CD80-, CD86-, and CD25-. while DC were CDla+'-D R " ' , CD23-. CD36-, CD80+, CD86". and CD25' . CD40 and CD32 were moderately expressed and nearly unchanged on maturation, in contrast to monocyte-derived DC. Macropinocytosis of fluorescein isothiocyanate-dextran was dominant in LC, as were multilamellar major histocompatibility complex (MHC) class II compartments (MIICs), which were detected by electron microscopy. The functional dichotomy of these cell types was finally supported by testing the AG-presenting cell function for tetanus toxoid to primed autologous T-cell lines, which was optimal when cells were loaded with AG as LC and subsequently induced to become DC. 0 1996 by The American Society of Hematology.
MA; IL-6 and granulocyte-macrophage colony-stimulating factor (GM-CSF) (kindly provided by L. F&ber, Sandoz, Ntirnberg, Germany); and erythropoietin (EPO; Cilag, Bad Homburg, Germany).
Human recombinant cytokines were used at a concentration of 10 nglmL (IL-10 and SCF), 50 ng/mL (IL-4), 100 ng/mL (IL-3, IL-6, and GM-CSF ), and 1 U/mL (EPO). Lipopolysaccharide (LPS, from Escherichia coli, serotype 01 11:B4; Sigma, St Louis, MO) was used at a concentration of 100 ng/mL.
Patients received two cycles of conventional-dose etoposide fVPl6). ifosfamide, and cisplatin (VIP), without or with epirubicin (VIP-E) at 3-week intervals." Granulocyte colony-stimulating factor (G-CSF Neupogen, Amgen, Basel, Switzerland) was administered to all patients at a dose of 5 pglkgld subcutaneously to prevent chemotherapy-associated neutropenia and to mobilize PBPC following chemotherapy. Mobilized PBPC were harvested by leukapheresis on day 10 or 11 after the second cycle of chemothenpy by leukapheresis. The CD34' progenitor cells were positively selected using the Ceprate avidinbiotin immunoadsorption column (Cellpro, Bothell, WA) as described."
Culture of LCDC from CD34+ PBPC. The culture of purified CD34+ cells was performed in supplemented RPMI/lO% FCS in the presence of different combinations of cytokines described in the Results (IL-lP, IL-3, IL-6, SCF, EPO, IL-4, and GM-CSF). Culture medium was replenished weekly. Cells were seeded at a concentra-tion of 5 x IO4 cellslmL in the beginning of culture, at a concentration of 5 X 105/mL in the second week, and at a concentration of 1 x IO6 cells/ml thereafter.
Surface marker analysis of in vitro-cultured cells was performed using a FACScan and the Lysis I1 software (Becton Dickinson, Mountain View, CA). We used the following monoclonal antibodies (Mabs) conjugated to fluorescein isothiocyanate (FITC) or phycoerythrin (PE) for direct fluorescence: CDla (Coulter Immunology, Hideah, FL, or Ortho Diagnostic Systems, Neckargemuend, Germany), CD1 Ib, CD23, CD25, CD33, CD36, CD44, CD54, CD58, CD64 (all from Immunotech, Marseille, France), CD4, CD14, CD16, HLA-DR, CD80, CD122 (all from Becton Dickinson), CD40, CD32, and CD86 (all from PharMingen, Hamburg, Germany).
Posifive selection of CDla' cells by immunoafinity adsorption columns. At day 21, cells were harvested, washed in phosphatebuffered saline (PBS; GIBCO, Grand Island, NY), and adjusted to I to 2 X IO7 cells/mL. The cells were incubated with a biotinylated immunoglobulin G2a (IgG2a) anti-CDla Mab (Becton Dickinson), washed, and loaded onto an avidin-immunoaffinity column (Ceprate LC system; CellPro). Adsorbed cells were removed from the column and resuspended in RPMI. An aliquot of the target cell population was analyzed to assess purity using a FACScan.
Cell suspensions were centrifuged at 200 X g (4°C) for IO minutes. The cell pellet was fixed for 12 hours at 4°C in 3% cacodylate-buffered glutaraldehyde (pH 7.35) and then transferred into 5% saccharose for electron microscopy (EM). Postfixation was performed with 1% osmium tetroxide and 0.05 molL kalium-ferricyanide. Specimens were then washed with distilled water, dehydrated in graded alcohols, and embedded in araldit resin. Ultrathin sections (50 nm) were cut and placed on copper grids. Sections were stained with 5% uranyl acetate and 0.2% lead citrate. Electron microscopy immunogold labeling was performed after microwave-osmium fixation," and a mouse Mab directed against HLA-DR (Dako, Hamburg, Germany) was used. Examination followed using a Philips CMlO electron microscope (Philips, Eindhoven, The Netherlands) operating at 80 kV.
We used the method of Sallusto et a13 to determine the endocytotic activity of in vitroFlow cytometry.
Electron microscopy.
Endocytosis assay with FITC-dextran. generated LC/DC. FITC-dextran was added to a final concentration of 1 mglmL to the cells, which were resuspended in RPMI plus 10% FCS. After incubation for 1 hour on ice or at 3 7 T , cells were washed four times with ice-cold PBS and analyzed on a FACScan. Dead cells were excluded using propidium iodide.
The method used to generate autologous tetanus toxoid ('IT)-specific Tcell lines has been described previo~sly.'~,'~ Briefly, peripheral blood lymphocytes (PBLs) isolated by Ficoll gradients from heparinized blood samples collected before chemotherapy were primed for 7 days in RPMI 1640 medium, supplemented with 10% human serum, antibiotics, L-glutamine, and IO mmol/L HEPES buffer, which contained TT at a concentration of 200 pg/mL (kindly provided by Dr Blackolb, Behring, Marburg, Germany). On day 7, IL-2 (25 UlmL) was added to the AG-primed T cells, which were then expanded for an additional 3 days before cryopreservation in aliquots. Primed T cells were thawed 2 days before the AG presentation experiments and cultured in medium that contained IL-2 (25 UlmL). APCs of the LC type were generated using CC3-2 as described in Table 1 and enriched to a purity greater than 90% at day 24. At day 26, these cells were split and cultured for another 60 hours in the presence of ( I ) CC4GM (LC); (2) CC4GM plus LPS (100 nglmg) (DC); (3) CC4GM plus TT (200 pglmL) for 3 hours, washed twice with RPMI. and further cultured in CC4GM (LC60); or (4) in CC4GM plus LPS ( I 00 nglmL) (DC60).
Following in vitro culture of LCDC from CD34+ PBPC, the cells were irradiated (40 Gy), washed, and used as APCs for the autologous TT-primed T cells. The assay was performed in 96-well flatbottom plates with a final volume of 200 pL/well. APCs were serially diluted, and 3 X 104/well responder T cells and 'IT AG were added as appropriate. The plates were incubated for 48 hours at 37°C in 5% C02. Subsequently, the wells were pulsed with 'H-thymidine ( I pCilwell), incubated overnight, harvested on filters, and counted by liquid scintillation.
AG presentation assay with autologous AG-spec$c T cells.

RESULTS
In the course of exploring the in vitro generation of DC from PBPC, we have shown previously that a combination For of early-acting hematopoietic growth factors (HGF), SCF, EPO, ILl-D. IL-3, and IL-6 (SE136) supplemented with IL-4 plus GM-CSF (CC4GM) is very potent for the generation of Birbeck granule-positive LC. However, differentiation and maturation continued under these culture conditions and the cells lost their immature phenotype progressively to become mature DCs of the interdigitating DC type.' To improve control of this process, attempts were made to separate a phase of PBPC expansion in the presence of SE136 as reported"' from a subsequent step in which CC4GM was used to induce LC/DC differentiation."' As another means to reduce the complexity of interactions, expansion cultures with only three HGFs were evaluated. The starting population of CD34' cells used in these experiments was enriched to 86% (range, 72% to 97%) and contained less than 2% CDla' cells (data not shown).
Comparing the different culture conditions and cytokine cocktails (CC) depicted in Table I , the overall cell yield after 3 and 4 weeks was comparable, with the exception of CC3-IL-4, where proliferation stopped and cells finally died after switching them from SCF+IL-3+IL-6 to IL-4 alone on day 8. Maximum cell numbers were obtained on day 21 and decreased subsequently. while absolute numbers of LC/ DC-like cells further increased in the presence of CC4GM only (CCS-2 and CC3-2) in contrast to CC7-7. The purity of LC/DC in CC3-2 ranged from 50% to 80%. Omitting EPO and IL-l during expansion from day 1 to 8 did not result in reduction of overall cell yield or numbers of LC/ DC-like cells. When the expanded cells were switched on day 8 to GM-CSF alone, most cells survived and matured along the monocyte/granulocyte pathway.
Phenotypic analysis of cultured PBPC demonstrated that almost all cells in the LC/DC gate (Fig I ) induced by CC3-2 were CDla" CD80-at day 26, while downregulation of CDla and concomitant increase of CD80 expression was observed in CC7-7. Interestingly, the amount of CDla++-cells still increased in the subsequent days of culture in CC3-2 (Table l ) without concomitant maturation (Fig l) , which suggests that new progenitor cells had matured up to this stage of differentiation and became stuck there. This state was maintained for up to I O days before a slow decrease of CD1 a and CD23 became detectable (not shown). In contrast, cells in the presence of CC7-7 had rapidly progressed further toward maturation with loss of CDla (Fig I ) and upregulation of CD80. Interestingly, the pronounced effects of CC7-7 on LC differentiation were paralleled by a much higher (15-fold) concentration of TNF-m in these cultures at day 21 as compared with CC3-2 (data not shown).
Having defined culture conditions that allow the maintenance of immature cells for several days, we wanted to purify high numbers of these cells to analyze their further development in detail under different conditions. CDla-cells were purified from primary cultures on day 26 by using a CDla Mab with an immunoaffinity column as described. This procedure generally allowed enrichment of CD1 a+ LC to greater than 90% as can be estimated by FACS analysis. When these cells were subsequently cultured for 60 hours in the presence of CC4GM (control), CC4GM plus TNF-(U, or CC4GM plus LPS, dramatic changes were observed upon addition of TNFa and LPS (Fig 2A) . Both induced a maturation of LC to DC with a more pronounced effect of LPS. The cells increased in size (FSC) and decreased in granularity (SSC). Expression of CDla, CD23, and CD36 was downregulated, while HLA-DR and CD86 increased, with the latter exhibiting the most dramatic positive shift (Fig 2A) . Most cells in CC4GM were CD86-and a high proportion was also CD80-as evidenced from Figs1 and 2A and B. In contrast to the Fce-receptor CD23, expression of Fcy-receptors CD16 and CD64 (negative) was unchanged and CD32 (low) expression was only slightly decreased upon TNF-a or LPS induction. The adhesion molecules CD54 and CD58 were weakly upregulated in DC, similar to the CD40 costimulatory molecule, while CDllb and CD44 had decreased in the DC stage, as did CD33. Expression of the IL-2-receptor-a-chain CD25 was markedly enhanced in LPS-induced DC, while &chain expression was negative. All of the cells were CD14-throughout culture.
To further substantiate the functional separation of AG uptake and AG presentation by LC and mature DC, respectively, we analyzed macropinocytosis of FITC-dextran by these defined DC subpopulations, which was shown to be an important uptake mechanism for AG in LC? As shown in Fig 3, LC were highly active to take up this substrate, while uptake was negligible in DC. The next steps after AG uptake relate to endosomal degradation and loading of peptide on major histocompatibility complex (MHC) class I1 molecules supposed to take place in MHC class I1 compartments (MIIC). As shown in Fig 4, gold-labeled anti-MHC-class I1 Mabs specifically stained these structures. They were present in large amounts in the majority of LCs generated from PBPCs, while they were absent or scarcely detected in DCs (not shown). A similar distribution of Birbeck granules has been reported previously. ' The functional activity of in vitro-generated LCDC was finally studied with respect to presentation of TT to primed autologous T cells. Since TT requires uptake, processing, and peptide presentation, the assay system is a broad test for the APC function. When LC-and LPS-induced (60 hours) DC were incubated with TT and responder T cells for 48 hours, LC were found to be the more potent stimulators, which suggests that AG uptake and processing were limiting.
However, when LC were incubated with TT for 3 hours and subsequently cultured in the presence of CC4GM (LC) or CC4GM plus LPS (DC) for 60 hours before being cocultured with primed autologous T cells, the DC fraction was found to be more potent than LC (Fig 5) . Due to a shorter incubation time and 2 days of culture without protein, overall proliferation of responder T cells was somewhat lower as compared with cells that had been cultured in the continuous presence of protein.
DISCUSSION
The in vitro generation of DC cells from hematopoietic progenitor cells (HPC) has been described by different groups using GM-CSF in combination with IL-4 or TNFAlthough GM-CSF is an important survival factor for LCDC in vitro,' it may not be crucial in vivo, since GM-CSF-'-mice are not deficient in DC. Interesting data were also reported from monocyte-derived DC (Mo-DC) that were generated in the presence of CC4GM.83'4 However, none of these studies addressed the specific requirements for the generation of immature LC and mature DC, respectively, which are distinct maturation steps in vivo as evidenced from homing and function with respect to AG uptake, processing, and presentation.' Here, we intended to extend earlier observations on the generation of LCDC in vitro by modifying culture conditions to generate these different cell types under controlled conditions.
In an attempt to separate PBPC expansion and specific differentiation by sequential use of early-acting HGFs on the one hand and the differentiation factors IL-4 + GM-CSF (CC4GM) on the other, we achieved an improved yield of CDla++ LC at lower costs ( Table 1 ). The continuous presence of SE136 plus CC4GM was found to be less effective at generating LCDC-like cells when compared with CC5-2 or CC3-2. The two-factor combination IL-4 plus GM-CSF added after 8 days of expansion in SCF+IL-3+IL-6 was able to somehow freeze the stage of LC differentiation for up to 10 days (Fig I) , while progressive maturation was observed in CC7-7, where secondarily induced TNF-a might have worked as a differentiation factor. The important role of TNF-a in LC/DC maturation was confirmed in experiments in which TNF-a was added to the CC4GM-maintained cultures (Fig 2) . This effect was even exceeded by LPS, thus corroborating data from Sallusto et al with Mo-DC.* Molecules important for AG uptake (CD23 and CD36)" were abundant in LC, while they were downregulated in TNF-a-or LPS-induced (60 hours) DC at the expense of molecules involved in AG presentation and T-cell costimulation (HLA-DR, CD80, and CD86). However, CD40, another costimulatory molecule, was consistently expressed at high levels in LC and DC. The FcyRII (CD32) was detected at low level on LC without major changes upon maturation. This is in line with data from cord blood-derived DC (CB-DC), but contrasts with the marked decrease of FcyRII expression in TNF-a-induced Mo-DC."" Discordant data were also reported for CD44 expression, which was upregulated in TNF-a-stimulated MO-DC; while it was decreased in TNF-a-and LPS-stimulated LC/DC derived from PBPC (PBPC-DC) (Fig 2B) . A comparative analysis of Mo-DC and PBPC-DC is needed to determine whether these differences reflect intrinsic differences of DCs generated from different sources. Macropinocytosis, which was shown to play a major role in AG uptake in MO-DC? was similarly found in PBPCderived LC. In both populations, it was drastically reduced after stimulation with TNF-a and LPS (Fig 3) , which supports the dichotomy of two functional stages of DC differentiation and suggests an important role of TNF-a in the functional switch. In line with these data, multilamellar MIIC structures, supposedly involved in loading of antigenic peptides on MHC class I1 molecule^,'^^^^ were found to be abundant in LC, in contrast to TNF-a-and LPS-induced DC; they thus exhibit a similar distribution as the expression of Birbeck granules, as reported previo~sly.~ In parallel with the decrease of MIIC, surface expression of MHC class I1 was upregulated and the overall cell surface was drastically expanded via an increase of dendritic processes. These phenomena may be linked due to a fusion of the MIIC compartments with the cell membrane induced by LPS or TNF-a.
When AG was added to LC or mature DC, T-cell stimulation of the former was superior, which suggests that uptake and processing were limiting factors. However, when cells were incubated with AG as LC and then kept in the LC state or induced to become DC, DC were more efficient at presenting the AG. Considering the different AG expression pattern and the distribution of MIICs in LC and DC, these data on T-cell stimulation corroborate the concept of a functional switch between these stages of DC differentiation.
In summary, we have shown that the sequential use of HPC-expanding factors followed by culture in the presence of differentiation (IL-4) and survival factors (GM-CSF) allows the generation of high numbers of a distinct LC subtype that contains abundant multilamellar MIICs and can be maintained in this stage for more than 1 week. Maturation is induced by TNF-a and LPS, and is associated with a down-modulation of the AG uptake and processing machinery, while the AG-presenting activity is at a maximum. The availability of large amounts of LCDC at both differentiation stages may help to further elucidate the peculiar characteristics of these cells and to define optimal conditions for in vitro loading with specific AGs. They may subsequently be used for an adoptive transfer in order to induce AGspecific responses in vivo with respect to tumors or infectious agents.
